Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus

Xiurong Ding1, Yanhua Yu1, Bichao Lu2

  • 1Department of Clinical Laboratory, Beijing YouAn Hospital, Capital Medical University, Beijing, P.R. China.

Insights

Hematological findings, including lymphopenia and leukopenia, were analyzed in COVID-19 patients. The neutrophil-to-lymphocyte ratio (NLR) showed relevance to hospitalization duration and prognosis in severe COVID-19 cases.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) poses a global health challenge, necessitating further research into patient severity and prognosis.
  • Understanding hematological alterations in COVID-19 is crucial for effective patient management.

Purpose of the Study:

  • To investigate the dynamic changes in hematological parameters among hospitalized COVID-19 patients.
  • To evaluate the clinical implications of these hematological findings, particularly in relation to disease severity and hospitalization duration.

Main Methods:

  • A retrospective analysis of 72 hospitalized COVID-19 patients was conducted.
  • Hematological parameters were tracked at multiple time points post-admission (days 1, 5, 7, 9, 11, 13, 15).
  • Comparison of hematological profiles between severe and non-severe cases, and correlation with hospitalization time.

Main Results:

  • Lymphopenia (54.2%) and leukopenia (27.8%) were common. Severe cases exhibited higher leukocyte and neutrophil counts, and elevated neutrophil-to-lymphocyte ratio (NLR) compared to non-severe cases.
  • Severe patients showed decreased lymphocyte counts throughout hospitalization.
  • Non-severe patients demonstrated an increasing trend in platelet count. A positive correlation between NLR and hospitalization duration was observed from day 5 onwards.

Conclusions:

  • Dynamic hematological profiles in severe versus non-severe COVID-19 patients during hospitalization were characterized.
  • The neutrophil-to-lymphocyte ratio (NLR) demonstrated relevance to hospitalization duration and potential utility in forecasting prognosis for COVID-19 patients.

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.0K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.2K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.9K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
7.9K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
454
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K